Automated microbiology market seen reaching $17.19 billion by 2030

The automated microbiology market is projected to grow from $10.63 billion in 2026 to $17.19 billion by 2030, driven by demand for faster, more accurate diagnostics and greater laboratory automation. North America held the largest regional share in 2025 as smart lab tools, AI pathogen identification and LIMS adoption gained traction.

Why it matters: - Automated microbiology helps labs process tests faster with fewer manual errors. - The market’s growth reflects stronger demand for rapid infectious disease testing and more precise diagnostics. - Health systems are under pressure to improve turnaround times and support treatment decisions sooner.

What happened: - The automated microbiology market rose from $9.4 billion in 2025 to a projected $10.63 billion in 2026. - The market is forecast to reach $17.19 billion by 2030. - The report projects a 13.0% CAGR in 2026 and a 12.8% CAGR from 2026 to 2030. - North America held the largest regional share of the market in 2025. - The Business Research Company published the forecast in its Automated Microbiology Global Market Report 2026. - The report covers North America, Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - Automated microbiology uses automated systems to perform microbiological procedures that were previously manual. - The main goals are higher efficiency, fewer human errors, better reproducibility and faster diagnostic turnaround times. - Clinical microbiology labs depend on these capabilities because faster results can affect patient care decisions. - Growth has been supported by rising clinical test volumes, demand for quicker diagnostics, hospital laboratory expansion, lab worker shortages and broader use of standardized procedures. - The report says future growth will be supported by investment in smart laboratory technologies, broader use of molecular microbiology, integrated data management systems and a stronger focus on diagnostic precision. - Emerging trends include fully automated microbiology platforms, AI-enabled pathogen identification, expanded use of Laboratory Information Management Systems, higher-throughput testing and more workflow automation. - The report also includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis.

Between the lines: - The forecast suggests automated microbiology is moving from a niche lab upgrade to a core operating tool for diagnostics. - The strong growth rate points to continued spending on lab efficiency as health systems try to handle more tests with fewer staff. - The emphasis on AI, LIMS and high-throughput testing shows the market is shifting toward connected, data-driven lab workflows rather than isolated instruments. - World Health Organization data cited in the report showed that in 2024 a Switzerland-based national agency reported 54% of 8.3 million newly diagnosed tuberculosis cases received an initial diagnostic test, up from 48% of 8.2 million in 2023.

What's next: - Market growth is expected to continue through 2030 as labs adopt more automated and integrated systems. - Demand should stay elevated for rapid infectious disease testing and molecular microbiology tools. - The report points to further expansion in high-throughput diagnostics and workflow automation across global laboratories. - The Business Research Company is also offering additional 2026 reports with updated graphics, dashboards and strategic market analysis.

The bottom line: - Automated microbiology is on a steady growth path, with diagnostics speed, precision and lab efficiency driving adoption worldwide.